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Carotid artery stenting: Is there a need to revise
ultrasound velocity criteria?
Brajesh K. Lal, MD,a Robert W. Hobson II, MD,a,b Jonathan Goldstein, MD,c Elie Y. Chakhtoura,
MD,c and Walter N. Dura´n, PhD,a,b Newark, NJ
Objectives: Ultrasound (US) velocity criteria have not been well-established for patients undergoing carotid artery
stenting (CAS). A potential source of error in using US after CAS is that reduced compliance in the stented artery may
result in elevated velocity relative to the native artery. We measured arterial compliance in the stented artery, and
developed customized velocity criteria for use early after CAS.
Methods: US was performed before and within 3 days after CAS, and after 1 month in a subset of 26 patients.
Post-procedural peak systolic velocity (PSV) and end-diastolic velocity (EDV) of the internal carotid artery (ICA),
PSV/EDV ratio, and internal carotid artery to common carotid artery ratio (ICA/CCA) were recorded. These were
compared with degree of in-stent residual stenosis determined at carotid angiography performed at the completion of
CAS. Peterson’s elastic modulus (Ep) and compliance (Cp) of the ICA were determined in a subgroup of 20 patients at
the distal end of the stent and in the same region in the native ICA before stenting.
Results: Ninety CAS procedures were analyzed. Mean (SD) angiographic residual stenosis after CAS was 5.4  9.1%,
whereas corresponding PSV by US was 120.4  32.4 cm/s; EDV, 41.4  18.6 cm/s; PSV/EDV ratio, 3.3  1.2; and
ICA/CCA ratio, 1.6  0.5. PSV was unchanged at 1 month. Post-CAS PSV and ICA/CCA ratio correlated most with
degree of stenosis (P < .0001 for both). Only six patients demonstrated in-stent residual stenosis 20% or greater, but the
standard US threshold of PSV 130 cm/s or greater (validated for >20% ICA stenosis in our laboratory) categorized 38
of 90 patients as having stenosis 20% or greater. Receiver operator curve analysis demonstrated that a combined threshold
of PSV 150 cm/s or greater and ICA/CCA ratio 2.16 or greater were optimal for detecting residual stenosis of 20% or
greater, with sensitivity 100%, specificity 98%, positive predictive value 75%, and negative predictive value 100%. After
placement of a stent, the ICA demonstrated significantly increased Ep (1.2 vs 4.4 103 mm Hg; P .004) and decreased
Cp (9.8 vs 3.2 %mm Hg  102; P  .0004).
Conclusions: Currently accepted US velocity criteria validated in our laboratory for nonstented ICAs falsely classified
several stented ICAs with normal diameter on carotid angiograms as having residual in-stent stenosis 20% or greater. We
propose a new criterion that defines PSV less than 150 cm/s, with ICA/CCA ratio less than 2.16, as the best correlate
to a normal lumen (0%-19% stenosis) in the recently stented ICA. This was associated with increased stiffness of the
stented ICA (increased Ep, decreased Cp). These preliminary results suggest that placement of a stent in the carotid artery
alters its biomechanical properties, which may cause an increase in US velocity measurements in the absence of a technical
error or residual stenotic disease. (J Vasc Surg 2004;39:58-66.)
Carotid artery stenting (CAS) has emerged as an alter-
native to carotid endarterectomy (CEA) in the manage-
ment of carotid stenosis under specific high-risk circum-
stances. These include recurrent stenosis after CEA,1,2
patients at high-risk with significant medical comorbid
conditions, anatomically inaccessible lesions above C2, and
radiation-induced stenoses.3 The ultimate value of CAS
compared with CEA will be based on ongoing prospective
randomized clinical trials.4-6 In the interim, however, the
number of patients undergoing CAS is increasing rapidly,
and these patients require intensive follow-up to monitor
for in-stent recurrent stenosis.7
Duplex ultrasound (US) scanning is the standard tech-
nique to follow up patients who have undergone CEA or
medical therapy alone. US velocities correlate with angio-
graphic percent stenosis in the native unstented carotid
artery,8 and the appropriate threshold velocities signifying
different degrees of stenoses have been intensively analyzed
and identified.9-11 However, US velocity criteria have not
been well-established in patients undergoing CAS. Two
studies have reported altered blood flow velocity after
carotid stent placement, which may adversely affect the
accuracy of duplex US scanning.12,13 These studies con-
cluded that US velocity measurements as an index of ste-
nosis are not reliable after stent placement. A potential error
in the interpretation of US velocity after CAS is failure to
recognize that placement of a stent alters the biomechanical
properties of the artery and changes its compliance (Cp). A
reduction in Cp will likely lead to elevated velocy. The
mechanism, magnitude, and significance of these alter-
ations is ill-defined, and emphasizes the need to develop
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customized velocity criteria for use in patients with im-
planted stents.
We compared post-CAS US velocity with angiographi-
cally measured residual in-stent stenosis, and analyzed our
data to develop modified velocity criteria for use in patients
who had undergone recent CAS procedures. We also mea-
sured Cp14 and modulus of elasticity (Ep)15 after CAS, and
compared these values with those in the native unstented
artery to quantify alterations in arterial stiffnes produced by
stent implantation.
METHODS
Patients. CAS was performed as part of an institu-
tional review board–approved program in patients with
symptomatic carotid stenosis 50% or greater or asymptom-
atic carotid stenosis 80% or greater. Eligibility was further
determined on the basis of published criteria for high risk.3
Patients with contralateral internal carotid artery (ICA)
occlusions undergoing CAS were excluded from this anal-
ysis. Complete angiographic and duplex US scanning data
were available for 90 CAS procedures performed between
September 1996 and March 2003, and were used for the
current study.
Clinical protocol for CAS. Patients were referred to
the program after eligibility was confirmed with history,
physical examination, and duplex US scanning. Clinical,
angiographic, and procedural data were recorded. We have
described our protocol for performing CAS.1,7,16,17 In
brief, all patients received aspirin and clopidogrel. The
procedure was performed with the patient under local
anesthesia, with heparin anticoagulation. Digital carotid
angiography was performed to verify the severity of steno-
sis. Self-expandable stents (WallStent, Meditech/Boston
Scientific, Minneapolis, Minn; Acculink carotid stent,
Guidant, Menlo Park, Calif) were used in all procedures.
An antiembolic filter device (Accunet; Guidant) was used
when the Acculink stent was delivered.
Measurement of residual stenosis with carotid an-
giography. On completion of the procedure, all patients
underwent ipsilateral cervical carotid angiography to ex-
clude significant residual in-stent stenosis. Angiograms
were obtained in anteroposterior, oblique, and lateral
views. The view demonstrating the highest degree of ste-
nosis was used for the study. The degree of stenosis was
determined with North American Symptomatic Carotid
Endarterectomy Trial (NASCET) criteria.18 The in-stent
least luminal diameter was compared with the distal nonta-
pering portion of the ICA serving as the reference segment.
Diameters were measured by an independent blinded ob-
server using a software program for quantitative digital
angiographic analysis available at the imaging station
(MDQM; MEDCON Telemedicine Technology, Living-
ston, NJ).
Measurement of residual stenosis with US. A US
examination was performed within 3 days of CAS. In a
subset of 26 patients, US examination was repeated at day
30. All examinations were performed in the same vascular
laboratory, with the same US machine, and the technolo-
gists were blinded to the results of carotid angiography.
Velocity in the ICA was determined at distal, middle, and
proximal portions of the stent. In addition, velocity was
measured at any area of in-stent narrowing identified on
B-mode images. Velocity was also measured at the distal
common carotid artery (CCA). Peak in-stent systolic veloc-
ity (PSV), end in-stent diastolic velocity (EDV), ratio of
in-stent PSV to EDV, and ratio of PSV within the stent to
that in the CCA proximal to the stent were recorded for
each US study. An angle of insonation of 60 degrees was
used, with angle correction where necessary.
Velocity criteria used in our vascular laboratory for
differentiating normal (0%-19% stenosis) from abnormal
(20% stenosis) native unstented carotid arteries are based
on a modification of the University of Washington criteria.9
They have been validated through an Intersocietal Com-
mission on Accreditation of Vascular Laboratories
(ICAVL) accreditation process. PSV less than 130 cm/s
signifies a normal arterial lumen (0%-19%), whereas PSV
between 130 and 210 cm/s signifies 20% to 49% stenosis.
The US machines used for the study were the same as those
used to develop and validate velocity criteria for native
CAS. To further validate the technique, we studied 10
patients who underwent CAS but had normal contralateral
ICAs, as determined at angiography, and measured the
corresponding PSV in the ICAs on post-procedure day 1.
Residual in-stent stenosis and technical failure of CAS was
defined as any residual stenosis 20% or greater.
Measurement of Ep and Cp. Ep15 and Cp14 of the
ICA were determined in a subgroup of 20 randomly se-
lected patients using B-mode US and digital planimetry.
Longitudinal B-mode video images of the artery were
recorded and digitized. Multiple snapshot images through
the cardiac cycle were then saved. Image analysis software
(ImagePro Plus 3.1; Media Cybernetics) was used to out-
line the lumen and measure diameters at fixed points. The
largest (systolic, Ds) and smallest (diastolic, Dd) luminal
diameters were used for the calculations.19 Measurements
were repeated three times, and expressed as the mean.
Pre-procedure images were obtained at the distal ICA
where it was free of significant atherosclerotic plaque. Post-
procedure images were obtained within 3 days of CAS at
the distal stent. Therefore measurements were made at the
distal end of the stent and in the same region in the native
ICA before stenting. Right arm systolic (Ps) and diastolic
(Pd) blood pressures were measured with a manual sphyg-
momanometer after confirming that there was no right-left
arm pressure differential. Ep was expressed in mm Hg, and
calculated as (Ps  Pd)/[(Ds  Dd)/Dd].15 Cp was
expressed as %mm Hg  102, and calculated as ([Ds 
Dd]/Dd)  104/(Ps  Pd).14
Statistical analysis. Data were expressed as mean 
SD. Comparison of US flow velocity measurements with
angiographic stenoses was accomplished with Pearson co-
efficient of correlation (Prism 3.0; GraphPad Software, San
Diego, Calif). Receiver operator characteristic (ROC)
curves were used to compare angiographic data with veloc-
ity measurements to determine optimum velocity criteria
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for ICA in-stent residual stenosis 20% or greater (SPSS
10.0; SPSS, Chicago, Ill). Sensitivity, specificity, positive
predictive value (PPV), and negative predictive value
(NPV) were determined for the velocity criteria. Pre-pro-
cedure and post-procedure Ep and Cp were compared with
t tests.
RESULTS
Patients. Ultrasound velocity and carotid angiogra-
phy data were available for comparison in 102 CAS proce-
dures. Of these, 12 were noted to have contralateral ICA
occlusions, and were excluded from the study. Observa-
tions from the remaining 90 procedures in 88 patients were
used for the study. Fifty-seven percent of the procedures
were performed to treat asymptomatic stenoses, and 43% to
treat symptomatic lesions. Indications for CAS included
recurrent stenosis after previous CEA (n  61, 68%),
primary lesions in patients at high risk (n  25, 28%), and
previous ipsilateral cervical radiation therapy (n  4, 4%).
Mean ( SD) age of the cohort was 71  8 years; 40
patients (45%) were female.
Distribution of velocity measurements. Carotid an-
giography at the end of the CAS procedures yielded a mean
( SD) residual in-stent stenosis of 5.4%  9.1% for the
entire cohort of 90 procedures. Corresponding US per-
formed within 3 days post-procedure demonstrated the
values for PSV to be 120.4  32.4 cm/s (range, 54-229
cm/s); EDV, 41.4  18.6 cm/s; PSV/EDV ratio, 3.3 
1.2; and ICA/CCA ratio, 1.6  0.5 (Table I).
Six patients demonstrated angiographic evidence of
residual in-stent stenosis 20% or greater immediately after
the procedure. At US examination within 3 days of CAS,
mean PSV (185  25.2 cm/s), EDV (56.3  28.1), and
ICA/CCA ratio (2.5  0.3) in these patients were signifi-
cantly different from those in patients without residual
in-stent stenosis (P  .0001, P  .04, P  .0001, respec-
tively).
Thirty-eight procedures had in-stent PSV ranging from
130 to 229 cm/s at post-procedure US measurement
(Table I; Fig 1). With ICAVL-approved velocity criteria for
native unstented carotid arteries established in our labora-
tory, clinically significant residual in-stent stenosis 20% or
greater would be diagnosed in all of these patients. There-
fore 42% of CAS procedures (38 of 90) would be classified
as technical failures. However, in marked contrast with the
assessment based on US, the mean angiographic stenosis
for these 38 procedures was 7.4%  9.9%.
All 6 patients with true angiographic evidence of resid-
ual in-stent stenosis 20% or greater had PSV 130 cm/s or
greater. However, the mean PSV and ICA/CCA ratio in
these six patients were significantly different from those in
the remaining 32 patients in this group (P .001, P .02,
respectively; Table I).
Scatter graphs of in-stent PSV, EDV, PSV/EDV ratio,
and ICA/CCA ratio were plotted as a function of angio-
graphic stenosis to demonstrate the magnitude and relative
prevalence of velocities measured in the study (Fig 1, A-D).
We next examined whether US velocity measurements
correlated with angiographic in-stent stenosis, and sought
to determine which of the measurements had the strongest
correlation. With Pearson’s coefficient, post-procedure in-
stent PSV, EDV, and ICA/CCA ratio correlated with
angiographic degree of stenosis. The correlation was stron-
gest for PSV (P .0001; r 0.43) and ICA/CCA ratio (P
 .0001; r  0.4), compared with EDV (P  .02; r 
0.25) and PSV/EDV ratio (P  .27; r  0.11).
During the most recent 26 CAS procedures we com-
pared PSV in patients with stents on post-CAS day 1 and
post-CAS day 30. In these patients, mean ( SD) PSV in
the stented ICA on day 1 was 109.5  42.7 cm/s, and on
day 30 was 104  32.3 cm/s. The results were not signif-
icantly different (P  .42), indicating that elevated PSV
persisted beyond the periprocedural period.
In this subset of patients we also noted that contralat-
eral ICAs were free of any stenosis in 10 patients, based on
angiograms. We reviewed the corresponding PSV mea-
sured at US on post-procedure day 1. In this cohort of
documented normal ICAs (n 10), mean ( SD) PSV was
83.8  16.64 cm/s. Therefore US in our vascular labora-
tory accurately classified these arteries as having less than
Table I. Distribution of ultrasound velocity measurements in CAS patients
Patient group n
Angiographic
stenosis (%) PSV (cm/s) EDV (cm/s) PSV/EDV ICA/CCA
All patients 90 5.4  9.1 120.4  32.4 41.4  18.6 3.3  1.2 1.6  0.5
Patients with PSV  130 52 3.8  8.0 98.9  22.3 32.2  11.8 3.5  1.2 1.4  0.5
Patients with PSV 130 38 7.4  9.9 155.3  31.9 52.3  19.5 3.3  1.2 1.9  0.5
Patients with PSV 130
and angiographic stenosis
20%
6 24.6  3.8 185.0  25.2 56.3  28.1 3.9  1.5 2.5  0.3
Patients with PSV  130
and angiographic stenosis
20%
32 4.1  7.4 141.0  12.4* 51.2  28.1 3.1  1.2 1.7  0.4†
Values represent mean  SD.
PSV, Peak systolic velocity; EDV, end-diastolic velocity; ICA/CCA, internal carotid artery–common carotid artery ratio.
*P  .001.
†P  .02.
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20% stenosis in all instances. The ICA PSV of these non-
stented arteries versus the stented arteries in the study was
significantly different (P  .01). This confirms that there
were no machine-induced or technique-induced systematic
differences in US measurements.
ROC curves. We then sought to determine the appro-
priate US velocity measurements that would discriminate
between normal (20%) and abnormal (20% stenosis)
stented arteries. ROC curves were generated for sensitivity,
specificity, PPV, and NPV of various US velocity measure-
ments for this purpose (Fig 2, A-D). A larger area under the
ROC curve is a measure of improved discrimination. Based
on these criteria, area under the curve ( SD) and signifi-
cance, with respect to the null hypothesis that there is no
discrimination, were calculated for the various US measure-
ments studied: PSV, 0.984 0.01, P .0001; ICA/CCA
ratio, 0.968  0.02, P  .0001; EDV, 0.667  0.11, P 
.17; and PSV/EDV, 0.648  0.15, P  .23. PSV and
ICA/CCA ratio demonstrated significant discriminant
ability, and further analysis was focused on these two
measurements.
Data derived from the ROC curves were used to
calculate the parameters of accuracy for PSV and ICA/
CCA ratio through a wide range of values to determine
the optimal threshold to identify 20% or greater in-stent
stenosis. The results are shown in Table II. A PSV
threshold of 130 cm/s or greater was noted to be a poor
discriminant: sensitivity was 100%, specificity was 63.1%,
PPV was 16.2%, and NPV was 100%. Specificity (96.4%)
and PPV (66.7%) were improved significantly when the
threshold was raised to 150 cm/s or greater. Similarly,
the optimal threshold ICA/CCA ratio was noted to be
2.16 or greater, for which sensitivity was 100%, specific-
ity was 95.1%, PPV was 60%, and NPV was 100%. Overall
PPV in identifying in-stent residual stenosis 20% or
greater was improved further by use of serial post hoc
analysis.11 Several combinations of PPV and ICA/CCA
ratio were tested (Table II). An optimal combined
threshold of in-stent PSV 150 cm/s or greater and
ICA/CCA 2.16 or greater achieved sensitivity of 100%,
specificity of 97.6%, PPV of 75%, NPV of 100%, and
accuracy of 97.7%.
Fig 1. Distribution of ultrasound velocity measurements with respect to corresponding degrees of angiographic
stenosis noted after carotid artery stenting. A, In-stent peak systolic velocity (PSV). B, In-stent end-diastolic velocity
(EDV). C, In-stent PSV/EDV ratio. D, In-stent PSV of internal carotid artery–common carotid artery ratio
(ICA/CCA).
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Measurement of Ep and Cp. After placement of a
stent, Ep of the ICA increased from 1.2 0.5 103 to 4.4
 2.4  103 mm Hg (P  .004). In addition, Cp of the
ICA was significantly decreased, from 9.8  3.1 to 3.2 
2.3 %mm Hg  102 (P  .0004; Fig 3, A, B).
DISCUSSION
Duplex US scanning offers several advantages in the
follow-up of patients treated with CAS. It is noninvasive,
safe, free of complications, readily available in vascular
laboratories around the country, and is associated with a
large experience with primary and recurrent carotid stenosis
of the native carotid artery. The utility of US scanning in
the detection of native carotid artery disease is well- docu-
mented,8-11 and has led to the use of PSV, EDV, PSV/
EDV ratio, and ICA/CCA ratio, alone or in combination,
to define normal and increasingly stenosed ICAs. Only two
published studies have so far addressed the application of
velocity criteria to assess the status of stented carotid arter-
ies. Robbin et al13 studied the use of US in the follow-up of
stented carotid arteries, and noted that velocity measure-
ments were unreliable after stenting. Similarly, Ringer et
al12 reviewed their experience with US immediately after
carotid stent placement, and concluded that strict velocity
criteria for recurrent stenosis were unreliable. Both groups
applied limited, randomly selected, velocity criteria to their
data, and did not perform a systematic analysis to confirm
their findings.
Fig 2. Receiver operator characteristics curves for various ultrasound velocity measurements for differentiating
between 20% or 20% angiographic residual in-stent stenosis immediately after carotid stenting. A, In-stent peak
systolic velocity (PSV; cm/s). B, In-stent end-diastolic velocity (EDV; cm/s). C, In-stent PSV/EDV ratio. D, In-stent
PSV of internal carotid artery–common carotid artery ratio (ICA/CCA).
JOURNAL OF VASCULAR SURGERY
January 200462 Lal et al
Even when laboratories use the same method for iden-
tifying ICA stenosis, US velocity criteria developed for a
given degree of stenosis may differ. Differences may be due
to variability in carotid angiogram measurements,20 scan-
ning techniques, or US machines.21 As a result, velocity
recorded in one laboratory may differ significantly from
that recorded in another laboratory.22 It has therefore been
recommended that each center audit its results, and de-
velop its own criteria based on the published experience of
other authors.9,11,22 Over the past decade our vascular
laboratory has been well served by velocity criteria devel-
oped through our ICAVL accreditation process for mea-
suring native CAS. The same US machine was used to
perform all the studies. In addition, in a cohort of angio-
graphically documented normal ICAs the mean ( SD)
PSV was 83.8 16.64 cm/s. Therefore US in our vascular
laboratory accurately classified these arteries as having less
than 20% stenosis in all instances. The mean PSV of normal
native ICAs was significantly lower than the PSV of angio-
graphically normal but stented arteries in the study (P 
.01). This serves to validate technical competence of the
vascular laboratory. This also confirms that our findings
were not related to machine-induced or technique-induced
systematic differences in US measurements.
In our cohort of 90 CAS procedures, 38 demonstrated
a mean PSV 130 cm/s or greater at post-procedure US
performed within 3 days. With the velocity criteria estab-
lished in our laboratory for unstented arteries, procedures
performed in these patients would be characterized as
technical failures, because of in-stent residual stenosis of
20% to 49%. However, only six procedures demonstrated
true angiographically proved residual stenosis 20% or
greater, and each had PSV 130 cm/s or greater. These
findings indicate that US velocity measurements are ele-
vated in many patients after stent placement and that veloc-
ity criteria designed to evaluate disease in native unstented
arteries should be revised for application in these patients.
Intraoperative US studies performed after CEA have noted
elevated velocities in a small subset of patients, and it has
been suggested that that this may be secondary to post-
reperfusion hyperemia. However, mean intraoperative ve-
locity after CEA in several large series has ranged from 69 to
88 cm/s.23-25 Conversely, mean intraoperative PSV has
been noted to be elevated in the presence of residual
stenosis.25 In addition, we compared PSV in 26 patients
with recent stent placement, on post-CAS days 1 and 30.
The mean PSV ( SD) in the stented ICA on day 1 was
109.5  42.7 cm/s, and mean PSV on day 30 was 104 
Table II. Parameters of in-stent PSV and ICA/CCA ratios for differentiation of 20% vs 20% in-stent residual
stenosis
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
ICA PSV 
100 100 31.0 9.4 100
110 100 36.9 10.2 100
120 100 45.2 11.5 100
130 100 63.1 16.2 100
140 100 86.9 35.3 100
145 100 94.0 54.5 100
150* 100 96.4 66.7 100
161 83.3 96.4 62.5 98.8
172 66.7 98.8 80.0 97.6
184 33.3 98.8 66.7 95.4
196 16.7 100 100 94.4
ICA/CCA 
1.50 100 54.8 13.6 100
1.75 100 69.0 18.7 100
2.00 100 86.9 35.3 100
2.06 100 90.5 42.9 100
2.16* 100 95.2 60.0 100
2.21 83.3 95.2 55.6 98.8
2.23 66.7 95.2 50.0 97.6
2.42 50.0 95.2 42.9 96.4
2.50 50.0 97.6 60.0 96.5
2.75 16.7 98.8 50.0 94.3
2.77 16.7 100 100 94.4
ICA PSV  and
ICA/CCA 
140, 2.0 100 95.2 60 100
140, 2.16 100 96.4 66.7 100
150, 2.0 100 96.4 66.7 100
150, 2.16* 100 97.6 75.0 100
161, 2.16 83.3 98.8 83.3 98.8
PSV, Peak systolic velocity; ICA, internal carotid artery; CCA, common carotid artery; PPV, positive predictive value; NPV, negative predictive value.
*Optimal value.
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32.3 cm/s. The results were not significantly different (P
.42). The elevated velocities were consistent, and persisted
to day 30. Therefore it is unlikely that the elevated velocity
in our patients after CAS was related to post-procedure
hyperemia.
It is clear, however, that PSV and the ICA/CCA ratio
do increase in the presence of in-stent stenosis. Mean PSV
and ICA/CCA ratio were both significantly higher in the
six patients with angiographic stenosis 20% or greater (PSV,
185.0  25.2 cm/s; ICA/CCA, 2.5  0.3 cm/s) than in
the remaining cohort with normal arterial lumens (0%-19%
stenosis; PSV, 115.8  27.6; ICA/CCA, 1.5  0.5 cm/s;
Table I). Even within the group demonstrating PSV 130
cm/s or greater (n 38), those with angiographic stenosis
20% or greater had PSV and ICA/CCA ratios significantly
higher than those with elevated velocity but no stenosis
(PSV, 141.0 12.4 cm/s; ICA/CCA, 1.7  0.4 cm/s;
Table I). However, correlation between velocity measure-
ments and degree of angiographic stenosis were modest.
This may be a reflection of inherent limitations of US and
carotid angiography or of the number of patients in the
study. This is reflected in the low PPV reported for PSV
(66.7%) and for ICA/CCA ratio (60%). A PSV of 130
cm/s or greater did not reliably identify in-stent residual
stenosis 20% or greater (sensitivity, 100%; specificity,
63.1%; PPV, 16.2%; NPV, 100%), and is not an appropriate
threshold value for identifying technical success or failure
after CAS. We conclude that a modification in flow velocity
criteria is required to improve reliability in discriminating
residual in-stent stenosis after CAS.
On the basis of ROC curve analysis of duplex US data,
we found that PSV 150 cm/s or greater in combination
with an ICA/CCA ratio 2.16 or greater provides optimal
sensitivity (100%), specificity (97.6%), PPV (75%), NPV
(100%), and accuracy (97.7%) for differentiating 0% to 19%
and 20% or greater ICA in-stent residual stenosis after CAS.
When PSV 150 cm/s or greater was used alone as a cutoff,
specificity was modestly lower (96.4%), but PPV dropped
significantly (66.7%). Similarly, an ICA/CCA ratio of 2.16
or greater serving as a threshold alone resulted in reduced
specificity (95.2%) and PPV (60%; Table II). Some studies
in native carotid arteries have demonstrated an advantage in
combining PSV and EDV in determining degree of steno-
sis.9,11 Our data failed to show a significant discriminant
ability of EDV alone (area under ROC curve, 0.667 
0.11; P  .17) or in combination with PSV or ICA/CCA
ratio.
In native ICAs, duplex US has been least satisfactory in
differentiating lesser degrees of stenosis.9 However, pub-
lished literature indicates that even lesser degrees of steno-
ses can be diagnosed with reasonable accuracy. Faught et
al9 reported an overall accuracy of 88.4% in detecting
carotid stenosis 30% or greater (sensitivity, 81%; specificity,
93.6%; PPV, 89.8%; NPV, 87.6%) and Hood et al26 re-
ported 93% accuracy in detecting 30% or greater stenoses
(sensitivity, 93.1%; specificity, 92.8%; PPV, 94.4%; NPV,
91.3%). Although the currently proposed revised criteria
for stented arteries provide high sensitivity, specificity,
NPV, and accuracy, it is possible that additional informa-
tion derived from B-mode imaging and spectral broaden-
ing may further improve the PPV and decrease the likeli-
hood of misinterpretation.9,27 For instance, in the presence
of a PSV 150 cm/s or greater and an ICA/CCA ratio 2.16
or greater, B-mode imaging may show no evidence of
luminal encroachment in the stent or there may be no
spectral broadening. These data may supplement the veloc-
ity criteria for determination of severity of in-stent stenosis.
The cause of the elevation in blood flow velocity noted
in this study has not been established. We report a signifi-
cant decrease in Cp (P .0004) of the ICA after placement
of a carotid stent. Cp is a material property measured by the
relationship between strain (fractional deformation of wall)
and stress (force per unit area of wall).28 In an artery, Cp is
described by the change in volume of a segment of artery in
relation to pulsatile change in blood pressure. Assuming a
cylindrical conformation for the arterial segment, the vol-
ume may be calculated as r2l (r, radius; l, length). Inas-
much as length is usually constant, the relative diameter
change per unit pressure has been used as an index of
changes in Cp.14,29 We also observed a significant increase
in Ep after stenting of the ICA (P .004). Peterson et al15
introduced Ep as a measure of the structural distensibility of
Fig 3. Measurement of elastic modulus (A) and compliance (B) of
native distal internal carotid artery versus stented distal internal
carotid artery; n  20 for each measurement. CAS, Carotid artery
stenting.
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the artery. Ep is inversely related to Cp, and both Cp and
Ep are measures of the stiffness of an artery. We speculate
that the stent-imparted increase in arterial stiffness may
explain the elevated flow velocities observed in our study.
Given that stents expand the arterial diameter and provide
mechanical support, we speculate that the enhanced stiff-
ness of the stent–arterial wall complex renders the flow-
pressure relationship of the carotid artery closer to that
observed in a rigid tube30; thus the energy normally applied
to dilate the artery results in increased velocity.
The interwoven mesh design of stents affords unique
mechanical properties. The Ep of stents is maximal when
completely constrained and when fully expanded, with lower
values between these states.31 The stent Cp and Ep therefore
vary with the diameter to which the stent has been expand-
ed.31 In addition, the arterial wall also contributes to the
overall stiffness of the stented site, and this varies according to
the amount of atherosclerosis and calcium load within the
wall.32 Therefore the final Cp and Ep of the stented ICA
would be altered to various degrees. This explains why US
velocity measurements were significantly elevated (130
cm/s) in 42% of patients but not all patients.
Our results demonstrate that the introduction of a stent
into the ICA alters arterial biomechanical properties. These
alterations may explain our observations that post-CAS US
velocities are elevated, as judged by criteria applied to native
arteries, in the absence of angiographic stenosis. We pro-
pose new US criteria consistent with the accepted defini-
tion of procedural success (20% residual stenosis) that will
most reliably discriminate normal from in-stent residual
stenosis (20%) immediately after CAS. These proposed
criteria can form the basis for additional prospective valida-
tion studies to further establish their utility in identifying
post-CAS stenosis. For this reason, we recommend early
registration of baseline velocity measurements after CAS,
against which future results can be compared. These find-
ings should encourage individual laboratories to interpret
elevated velocity after CAS with caution and to reexamine
their US criteria to establish new values appropriate to their
own experience.
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DISCUSSION
Dr A. R. Naylor (Leicester, England). I was very interested in
your paper. Could you explain to me—I may have missed the
emphasis—why did you choose 20% stenosis?
Dr Brajesh K. Lal. Twenty percent has been the standard
definition of in-stent residual stenosis, in most of the clinical trials,
and determines technical failure of the procedure. It is based on
angiographic measurements; and therefore we decided to transfer
that experience and determine ultrasound characteristics that
would define technical failure.
Dr Naylor. Sure, I accept that. But it is of completely no
relevance clinically.
Dr Lal. I think there is relevance. The purpose of this study
was to be able to identify whether or not placement of a stent does
indeed alter velocity measurements.
Dr Naylor. I don’t dispute that. But the fact that you’re
looking at a 20% threshold is of no clinical relevance at all.
Dr Lal. It defines technical failure. That’s Number 1.
And there is evidence in the coronary literature that a higher
incidence of residual stenosis translates into a higher incidence of
in-stent restenosis during follow-up. And that was the rationale.
Dr John Blebea (Hershey, Pa). Dr Lal, this was a very nice
study and presentation.
To expand on the previous comment, most vascular laborato-
ries have stopped attempting to define and quantify degrees of
stenosis of less than 50% for carotid lesions. I am therefore also not
sure of the clinical relevance or the reproducibility of trying to
quantify such a minimal degree of stenosis.
To carry this analysis further, how many of these patients had
a change in ultrasound velocity measurements that would have
defined greater than 50% stenosis, or did you not have any patients
that would fit that criterion? Because I think that is a more clinically
relevant group. Do criteria need to be redefined for stenosis greater
than 50% in patients who have had a carotid stent placed?
Dr Lal. The purpose of this study was to identify whether
altered biomechanical properties consequent to stent placement
were associated with an elevation in velocity measurements. None
of these patients had in-stent residual stenoses greater than or
equal to 20%. However, 38 of 90 procedures were categorized as
having 20% stenosis, and in two instances 50% stenosis, when using
ultrasound criteria for native (unstented) arteries. This is the most
important finding in the study.
Therefore, when following up recently stented patients, espe-
cially if one has not performed the procedure themselves, and a
peak systolic velocity of 150 cm/s is encountered, vascular labora-
tories should be aware that a stent could lead to elevated velocity
measurements. Each vascular laboratory may therefore have to
establish revised velocity criteria for the evaluation of patients with
stented, as opposed to native, carotid arteries.
Dr Kevin G. Burnand (London, England). Three quick
questions.
First of all, could the angiography be wrong?
Second, did velocity change over time?
And third, although you excluded occlusions, you didn’t tell
us about people with tight stenosis on the other side, which might
also have had an effect.
Dr Lal. Multiplanar angiography was performed, and the
degree of stenosis was digitally determined from the view demon-
strating the highest percent stenosis per NASCET criteria. This is
currently the most accurate method of determination of degree of
stenosis.
As our data for 26 patients demonstrate, velocity did not
change appreciably over 1 month.
We excluded contralateral stenoses of50% to eliminate their
effect on ipsilateral velocity measurements.
Dr Roy K. Greenberg (Cleveland, Ohio). I thought that was
a very interesting paper, as well, and I had two questions pertaining
more to your analysis of the biomechanical properties of the arterial
wall.
Regarding your ultrasound assessment: what ability did you
have to discriminate two different diameters? What was the reso-
lution of the B-mode images that you were assessing?
The second question relates to the fact that most of your
patients were really repeat carotid patients. Did you compare
repeat patients with patients who underwent primary stenting to
evaluate if differences existed regarding the stiffness, plaque mor-
phology, and arterial wall issues that may affect the biomechanical
properties?
Dr Lal. We did not measure resolution in our own study;
however, multiple studies have validated the resolution of echo
planimetry or digital planimetry with respect to ultrasound B-
mode determination of intima-media thickness measurements.
The resolution ranges from 200 to 250 m.
To answer your second question, the number of patients that
we have performed this procedure on is too low to perform subset
analysis. However, your question is valid. If there is an artery that
has calcification and atherosclerotic disease to begin with, the
ultimate stent-arterial complex would have a much lower compli-
ance than if a stent was placed in an intimal hyperplastic lesion. This
may explain why several, but not all, of our patients demonstrated
elevation in post-stenting velocity.
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